Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor, Adult

Explore clinical trials studying Solid Tumor, Adult. Study availability and eligibility vary by location and protocol.

199 public trials 80 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor, Adult trial results

Recruiting

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

NCT03465592

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +3 more
Locations
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Albert Einstein College of Medicine, Children's Hospital at Montefiore The Bronx, New York, United States
  • New York Medical Center/ Maria Fareri Children's Hospital Valhalla, New York, United States
View Trial Details
Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

NCT06265727

Conditions
Solid Tumor, Adult
Locations
  • O'Neal Comprehensive Cancer Center at University of Alabama-Birmingham Birmingham, Alabama, United States
  • City of Hope Cancer Center Duarte, California, United States
  • Moores Cancer Centre at UC San Diego Health San Diego, California, United States
  • Helen Diller Family Comprehensive Cancer Center - UCSF San Francisco, California, United States
View all 41 locations
View Trial Details
Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

NCT05856981

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC, Colorectal Cancer, +47 more
Locations
  • Henry Ford Cancer Institute Detroit, Michigan, United States
  • Washington University Medical Campus St Louis, Missouri, United States
  • Gabrail Cancer & Research Center Canton, Ohio, United States
  • Virginia Cancer Specialists Fairfax, Virginia, United States
View Trial Details
Recruiting

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

NCT06228326

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
Locations
  • XCancer Research Network/Dothan Hematology & Oncology Dothan, Alabama, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Precision NextGen Oncology Beverly Hills, California, United States
  • Emad Ibrahim MD Inc Redlands, California, United States
View all 14 locations
View Trial Details
Recruiting

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

NCT05216432

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California-San Diego San Diego, California, United States
  • HealthONE Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View all 37 locations
View Trial Details

Related conditions